Leadership from the Five Eyes cybersecurity agencies have published a joint statement regarding artificial intelligence (AI) and its impact on cybersecurity.
This on-demand webinar explores laboratory strategies to reduce sample cancellations due to hemolysis, improve specimen quality, and manage hemolyzed specimens. Continuing education credit will be offered.
bioMérieux announced that they have submitted a Dual 510(k)/CLIA Waiver application to the U.S. Food and Drug Administration (FDA) for the BIOFIRE SPOTFIRE Vaginitis (VG) Panel. The panel represents bioMérieux’s first step into women’s and sexual health testing.
